secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0000950170-23-058528
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo shareholders approve 2023 ESPP but reject officer exculpation amendment
--------------------------------------------------------------------------------

- 2023 ESPP approved with 91.11% of votes cast; reserves 45,000 shares; effective October 31, 2023.
- Amendment to certificate of incorporation (officer exculpation) failed: 794,723 for, 63,936 against; needed majority of 8,718,203 outstanding shares.
- Directors Keith Murphy (786,897 for) and Adam Stern (812,172 for) elected as Class III directors until 2026.
- Ratification of auditor Rosenberg Rich Baker Berman P.A. approved by 91.83% of votes cast.
- Advisory vote on named-executive compensation approved by 85.78% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/onvo-20231031.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-058528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer